Hu Dingtao相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Deciphering lung adenocarcinoma heterogeneity: a multi-omics approach reveals nuclear division fibroblasts as prognosticators and therapeutic targets

解读肺腺癌异质性：多组学方法揭示核分裂成纤维细胞作为预后指标和治疗靶点

期刊:Journal of Translational Medicine

影响因子:7.5

doi:10.1186/s12967-026-08022-3

Cao, Peng; Qin, Yongxia; Hu, Dingtao; Ge, Tengfei; Zhang, Peng; Cheng, Chao; Wang, Shun; Hu, Shuhui; Zhang, Zhen; Xu, Ling

成纤维细胞

细胞生物学

发表日期：2026

文献求助收藏

Integrative multi-omics and machine learning reveal critical functions of proliferating cells in prognosis and personalized treatment of lung adenocarcinoma

整合多组学和机器学习揭示增殖细胞在肺腺癌预后和个体化治疗中的关键作用

期刊:npj Precision Oncology

doi:10.1038/s41698-025-01027-z

Wang, Shun; Hu, Dingtao; Wang, Ruohuang; Huang, Jie; Wang, Baoqing

细胞生物学

发表日期：2025

文献求助收藏

Deciphering key roles of B cells in prognostication and tailored therapeutic strategies for lung adenocarcinoma: a multi-omics and machine learning approach towards predictive, preventive, and personalized treatment strategies.

揭示 B 细胞在肺腺癌预后和个体化治疗策略中的关键作用：一种多组学和机器学习方法，用于预测、预防和个性化治疗策略

期刊:Epma Journal

影响因子:5.9

doi:10.1007/s13167-024-00390-4

Zhang Jinjin, Hu Dingtao, Fang Pu, Qi Min, Sun Gengyun

细胞生物学

发表日期：2025

文献求助收藏

Oncofetal MCB1 Is a Functional Biomarker for HCC Personalized Therapy.

癌胚MCB1是肝细胞癌个体化治疗的功能性生物标志物

期刊:Advanced Science

影响因子:14.1

doi:10.1002/advs.202401228

Xiang Daimin, Liu Junyu, Wang Yichuan, Hu Dingtao, Zhang Cheng, Zeng Tanlun, Jiang Weiqi, Liang Xijun, Dong Wei, Sun Wen, Xu Li, Li Hengyu, Shi Yihai, Zhang Jian, Liu Hui, Ding Jin

细胞生物学

发表日期：2024

文献求助收藏

Predictive value of peripheral blood leukocytes-based methylation of Long non-coding RNA MALAT1 and H19 in the chemotherapy effect and prognosis of gastric cancer

外周血白细胞中长链非编码RNA MALAT1和H19甲基化水平对胃癌化疗效果和预后的预测价值

期刊:Translational Oncology

影响因子:4.1

doi:10.1016/j.tranon.2024.101929

Wang, Fang; Hu, Dingtao; Lou, Xiaoqi; Wang, Linlin; Wang, Yuhua; Zhang, Tingyu; Yan, Ziye; Meng, Nana; Lei, Yu; Zou, Yanfeng

细胞生物学

发表日期：2024

文献求助收藏

Machine learning-based biomarker screening for acute myeloid leukemia prognosis and therapy from diverse cell-death patterns

基于机器学习的生物标志物筛选，用于从多种细胞死亡模式中预测急性髓系白血病的预后和治疗

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-024-68755-3

Qin, Yu; Pu, Xuexue; Hu, Dingtao; Yang, Mingzhen

细胞生物学

发表日期：2024

文献求助收藏

DDR1 is a Novel Biomarker and Potential Therapeutic Target for the Combination Treatment of Liver Hepatocellular Carcinoma

DDR1是一种新型生物标志物，也是肝细胞癌联合治疗的潜在治疗靶点。

期刊:Cancer Control

影响因子:2.6

doi:10.1177/10732748241286257

Li, Tianxing; Hu, Hao; Song, Yuhao; Shi, Yihai; Hu, Dingtao; Shen, Weifeng; Ning, Beifang

细胞生物学

发表日期：2024

文献求助收藏

Genetic landscape and clinical significance of cuproptosis-related genes in liver hepatocellular carcinoma

肝细胞癌中铜凋亡相关基因的遗传图谱和临床意义

期刊:Genes and Diseases

doi:10.1016/j.gendis.2023.03.010

Hu, Dingtao; Wang, Yichuan; Shen, Xu; Mao, Tiantian; Liang, Xijun; Wang, Tengjiao; Shen, Weifeng; Zhuang, Yugang; Ding, Jin

细胞生物学

发表日期：2024

文献求助收藏

Multi-omic profiling reveals potential biomarkers of hepatocellular carcinoma prognosis and therapy response among mitochondria-associated cell death genes in the context of 3P medicine

多组学分析揭示了线粒体相关细胞死亡基因中与肝细胞癌预后和治疗反应相关的潜在生物标志物，该研究基于第三方药物（3P医学）的视角。

doi:10.1007/s13167-024-00362-8

Hu, Dingtao; Shen, Xu; Gao, Peng; Mao, Tiantian; Chen, Yuan; Li, Xiaofeng; Shen, Weifeng; Zhuang, Yugang; Ding, Jin

细胞生物学

发表日期：2024

文献求助收藏

Identification and validation of a cellular senescence-related lncRNA signature for prognostic prediction in patients with multiple myeloma

鉴定和验证一种与细胞衰老相关的lncRNA特征，用于多发性骨髓瘤患者的预后预测

期刊:Cell Cycle

影响因子:3.4

doi:10.1080/15384101.2023.2213926

Zeng, Tanlun; Jiang, Sihan; Wang, Yichuan; Sun, Guanqun; Cao, Jinjin; Hu, Dingtao; Wang, Guang; Liang, Xijun; Ding, Jin; Du, Juan

细胞生物学

多发性骨髓瘤

发表日期：2023

文献求助收藏